Design and setting
breast cancer
ONCOLOGY, BREAST CANCER
This interventional parallel clinical trial was conducted between February 2021 and December 2022 using before-after design with an active control group and a 1-month follow-up. The statistical population of this research was all women with breast cancer who had referred to Shahid Ramezanzadeh Radiation Oncology Center in Yazd for treatment. To conduct the research, written informed consent was obtained from all the participants. Eligible participants were contacted based on the list available in the center according to the inclusion criteria. The samples were selected based on the inclusion criteria by reviewing the available records. Among the participants who had referred to Ramazanzadeh Radiation Oncology Center in Yazd, the information of 550 patients with breast cancer was checked and of these, 165 participants were invited to participate in the study through phone calls. Finally, 80 participants who met the inclusion criteria entered the study. The required sample was determined using the following formula in each group.According to Hummel et al.’s paper [